These answers draw in part from “Development and Preliminary Validation of a Decision Making Tool for Determining Treatment Dosage in Applied Behavior Analysis Therapy” by Lauryn Toby, Ph.D., BCBA (BehaviorLive), and extend it with peer-reviewed research from our library of 27,900+ ABA research articles. Clinical framing, BACB ethics code references, and cross-links below are synthesized by Behaviorist Book Club.
View the original presentation →Treatment dosage refers to the number of hours of ABA therapy a client receives per week. It matters because dosage directly affects treatment outcomes: too few hours may produce insufficient progress, while too many hours may burden the client and family without proportional benefit. Dosage is also the primary driver of service cost, making it the variable that most affects insurance authorization, family financial burden, and organizational revenue. Despite its importance, dosage determination in ABA currently lacks standardized tools, relying primarily on individual clinical judgment.
Clinical judgment is influenced by training background, organizational culture, cognitive biases, and personal experience in ways that introduce systematic variability into dosage recommendations. Practitioners trained in different programs may anchor to different default intensities. Organizations with financial incentives for higher hours may create implicit pressure. Recency bias may cause over-reliance on recent cases. These influences are not eliminated by experience; they are embedded in the judgment process itself. Supplementing judgment with structured, data-driven decision frameworks reduces these sources of error.
Key variables include severity of presenting concerns, current learning rate as measured by baseline and initial treatment response, severity and complexity of challenging behavior, caregiver capacity and engagement, availability of complementary services, the individual's age and developmental trajectory, environmental stability, and the specific goals being targeted. Each variable can be measured and contributes information about how many professional service hours are likely needed to produce meaningful progress. A systematic framework weights these variables to generate a recommendation range.
At minimum, dosage should be formally reassessed quarterly, with interim reviews triggered by significant changes in the client's presentation, environment, or progress. Many clients remain at their initial dosage for months or years without systematic re-evaluation, even when clinical circumstances have changed substantially. Progress data, skill acquisition rates, challenging behavior trends, and changes in complementary services or caregiver capacity should all inform dosage adjustments. Documentation of the rationale for maintaining or changing hours at each review strengthens clinical reasoning and insurance justification.
Insurance companies evaluate medical necessity for requested hours based on clinical documentation. When dosage recommendations are supported by a systematic framework that connects specific clinical variables to the recommended intensity, the medical necessity argument is stronger than when the recommendation rests on clinical judgment alone. A dosage tool generates consistent, data-driven documentation that clearly demonstrates the relationship between the client's needs and the requested hours, reducing the arbitrariness that insurance reviewers may challenge.
A well-designed dosage tool should distinguish between clinically indicated hours and practically achievable hours. The clinical recommendation represents the optimal intensity based on the client's needs. Practical constraints, including family schedule, transportation, and sibling care needs, may reduce what is actually delivered. Documenting both the clinical recommendation and the practical modification ensures transparency: the client's record shows what they need and what they received, and any gap between the two is visible for clinical monitoring and advocacy purposes.
Over-recommendation subjects clients to unnecessarily intensive schedules that may reduce family time, limit access to other activities, and contribute to treatment fatigue. For young children, excessive therapy hours can displace play, social interaction, and rest that are important for development. For families, over-recommendation creates financial burden and scheduling stress. For the field, patterns of over-recommendation erode insurance company confidence and contribute to more aggressive utilization management that affects all practitioners and clients.
Code 2.01 requires effective treatment, which includes appropriate intensity. Code 2.13 requires sound assessment practices, which applies to the assessment process underlying dosage recommendations. Code 2.04 addresses third-party involvement, relevant when insurance or organizational interests influence dosage decisions. Code 1.05 protects professional judgment, but only when that judgment is defensible. Collectively, these codes establish that dosage determination should be a systematic, evidence-informed clinical process rather than an impressionistic estimate.
Document your clinical rationale for your recommended hours with specific reference to assessment data and client variables. Present this documentation to your supervisor with reference to Code 1.05 (Independence and Professional Judgment) and Code 2.01 (Providing Effective Treatment). If pressure persists, document the conflict. If organizational policy systematically overrides clinical judgment on dosage, this represents a systemic ethical concern that may warrant consultation with the BACB or a peer ethics consultation group. Your obligation is to the client's welfare, and recommending hours you believe are excessive violates that obligation.
The course describes a tool in preliminary validation, meaning it has been developed and is undergoing initial testing but has not yet been fully validated. Practitioners should approach it as a promising framework that informs clinical thinking rather than a validated instrument for direct clinical application. Following the validation process, reviewing published results, and considering the tool as a supplement to clinical judgment is appropriate at this stage. Full adoption should await sufficient validation data demonstrating reliability and validity across clinical populations.
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Ready to go deeper? This course covers this topic with structured learning objectives and CEU credit.
Development and Preliminary Validation of a Decision Making Tool for Determining Treatment Dosage in Applied Behavior Analysis Therapy — Lauryn Toby · 1 BACB General CEUs · $25
Take This Course →We extended these answers with research from our library — dig into the peer-reviewed studies behind the topic, in plain-English summaries written for BCBAs.
279 research articles with practitioner takeaways
258 research articles with practitioner takeaways
252 research articles with practitioner takeaways
1 BACB General CEUs · $25 · BehaviorLive
Research-backed educational guide with practice recommendations
Side-by-side comparison with clinical decision framework
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.